
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $1.3B | -- | -- | $0.30 | -- |
08/06/2025 | Q2 | $1.2B | -- | -- | $0.29 | -- |
05/07/2025 | Q1 | $1.4B | $1.4B | $0.44 | $0.42 | $0.02 |
02/25/2025 | Q4 | $1.3B | $1.3B | $0.29 | $0.34 | -$0.05 |
11/06/2024 | Q3 | $1.2B | $1.2B | $0.53 | $0.32 | $0.21 |
08/06/2024 | Q2 | $1.2B | $1.2B | $0.36 | $0.38 | -$0.02 |
05/07/2024 | Q1 | $1.2B | $1.2B | $0.25 | $0.38 | -$0.13 |
02/27/2024 | Q4 | $1.1B | $1.1B | $0.51 | $0.36 | $0.15 |
11/07/2023 | Q3 | $745.2M | $758.5M | $0.13 | $0.38 | -$0.25 |
08/02/2023 | Q2 | $643.1M | $623.4M | $0.21 | $0.32 | -$0.11 |
05/08/2023 | Q1 | -- | $616.3M | $0.31 | -- | -- |
02/22/2023 | Q4 | -- | $761.6M | $0.26 | -- | -- |
11/08/2022 | Q3 | -- | $549.8M | $0.70 | -- | -- |
08/03/2022 | Q2 | -- | $472.7M | $0.60 | -- | -- |
03/31/2022 | Q1 | -- | $347.3M | $0.05 | -- | -- |
12/31/2021 | Q4 | -- | $316.4M | $0.51 | -- | -- |
09/30/2021 | Q3 | -- | $288.5M | $0.12 | -- | -- |
06/30/2021 | Q2 | -- | $232.6M | -$0.09 | -- | -- |
03/31/2021 | Q1 | -- | $192.4M | -$0.12 | -- | -- |
12/31/2020 | Q4 | -- | $148.1M | -$0.32 | -- | -- |
09/30/2020 | Q3 | -- | $149.1M | -$0.19 | -- | -- |
06/30/2020 | Q2 | -- | $90.5M | $0.02 | -- | -- |
03/31/2020 | Q1 | -- | $192.8M | -$1.99 | -- | -- |
12/31/2019 | Q4 | -- | $256.4M | $0.03 | -- | -- |
09/30/2019 | Q3 | -- | $229.1M | -$0.01 | -- | -- |
06/30/2019 | Q2 | -- | $244.2M | $0.07 | -- | -- |
03/31/2019 | Q1 | -- | $214.6M | -$0.03 | -- | -- |
12/31/2018 | Q4 | -- | $222.5M | $0.12 | -- | -- |
09/30/2018 | Q3 | -- | $234.9M | $0.15 | -- | -- |
06/30/2018 | Q2 | -- | $217.8M | $0.24 | -- | -- |
03/31/2018 | Q1 | -- | $215.9M | $0.25 | -- | -- |
12/31/2017 | Q4 | -- | $166.1M | $0.12 | -- | -- |
09/30/2017 | Q3 | -- | $111.6M | $0.06 | -- | -- |
06/30/2017 | Q2 | -- | $91.1M | $0.09 | -- | -- |
03/31/2017 | Q1 | -- | $61.1M | $0.04 | -- | -- |
12/31/2016 | Q4 | -- | $29.7M | -$0.05 | -- | -- |
09/30/2016 | Q3 | -- | $27.3M | -$0.08 | -- | -- |
06/30/2016 | Q2 | -- | $23.3M | -$0.26 | -- | -- |
03/31/2016 | Q1 | -- | $15.1M | -$1.12 | -- | -- |
Permian Resources reported $1.4B worth of top line sales in its most recent quarter.
Permian Resources announced earnings per share of $0.44 which represents a beat of analyst forecast a $0.42 per share.
Permian Resources reported $676M that represents $0.90 per share over the last quarter.
Permian Resources's earnings are forecast to decrease from $1.45 per share to $1.48 per share next year representing a decrease of -5.9%.
Permian Resources's next earnings date is August 6, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.